This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

SCREEN-HFL (SCReening Evaluation of the Evolution of New Heart Failure) - a Longitudinal Study (SHF-L)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Health and Medical Research Council, Australia
Information provided by (Responsible Party):
Ingrid Hopper, Monash University
ClinicalTrials.gov Identifier:
NCT01581827
First received: April 12, 2012
Last updated: April 9, 2017
Last verified: April 2017
  Purpose

Heart failure (when the heart does not pump as well as it used to) is a medical condition which reduces the quality of life for the sufferers. Approximately 10% of people in western societies aged over 75 develop heart failure. There has been a shift towards prevention of this disease and it is hoped that BNP (brain natriuretic peptides) and NT-proBNP (N-terminal proBNP) will prove to be useful indicators of those at greatest risk. The current study therefore plans to follow up the 3500 participants at risk of heart failure from the original SCREEN-HF study.

Participants who are willing to participate will be contacted annually. They will undergo a short physical exam, will be asked to complete a Quality of Life questionnaire and will have a blood sample taken. At the end of the study participants will also have an ECG and an echocardiogram.


Condition
Heart Failure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: SCREEN-HFL (SCReening Evaluation of the Evolution of New Heart Failure) - a Longitudinal Study

Resource links provided by NLM:


Further study details as provided by Ingrid Hopper, Monash University:

Primary Outcome Measures:
  • Change in NT-proBNP [ Time Frame: baseline and 5 years ]
  • Change in echocardiogram [ Time Frame: baseline and 5 years ]

Secondary Outcome Measures:
  • incidence of new heart failure [ Time Frame: baseline and 5 years ]

Biospecimen Retention:   Samples Without DNA
Blood samples to measure BNP and NT-proBNP

Estimated Enrollment: 3500
Study Start Date: January 2009
Estimated Study Completion Date: December 2017
Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
Study population
People at high risk of heart failure (from SCREEN-HF study)

  Eligibility

Ages Eligible for Study:   60 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
People at high risk of heart failure
Criteria

Inclusion Criteria:

  1. Consented and enrolled in the SCREEN-HF study and who agreed to further contact
  2. Age ≥ 60 years
  3. Subjects at high-risk of subsequent development of heart failure; comprising at least one of:

    • Prior myocardial infarction (MI) without known left ventricular (LV) dysfunction
    • Current active ischaemic heart disease
    • Prior Cerebrovascular Accident (CVA)
    • Known valvular heart disease without known LV dysfunction
    • Atrial fibrillation
    • Treated hypertension, of at least 2 years duration
    • Treated Diabetes mellitus, of at least 2 years duration
    • Chronic renal impairment (eGFR < 60 ml/min)

Exclusion Criteria:

  1. Known systolic or diastolic heart failure
  2. LV systolic or diastolic dysfunction on echocardiography or other objective imaging modality (if known).
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01581827

Locations
Australia, Victoria
Monash University
Caulfield, Victoria, Australia, 3162
Sponsors and Collaborators
Monash University
National Health and Medical Research Council, Australia
Investigators
Principal Investigator: Henry Krum, MBBS FRACP PhD Monash University/Alfred Hospital
  More Information

Responsible Party: Ingrid Hopper, Senior Lecturer, Monash University
ClinicalTrials.gov Identifier: NCT01581827     History of Changes
Other Study ID Numbers: 52/09
Study First Received: April 12, 2012
Last Updated: April 9, 2017

Keywords provided by Ingrid Hopper, Monash University:
Heart Failure
BNP
NT-proBNP

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on August 16, 2017